Article
Biomarkers in colorectal cancer: Current clinical utility and future perspectives
6 Dec 2018
Abstract excerpt
gene mutations with the subsequent choice to administer targeted adjuvant therapy with anti-epidermal growth factor receptor antibodies. Moreover, CRC patients can benefit from tests for microsatellite instability and for the detection of loss of heterozygosity of chromosome 18q that can be helpful in guiding therapeutic decisions as regards the administration of 5-FU. The aim of this review was to summarize the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
